SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015Dose optimization for combinations of three or more drugs: an application to dose selection in regimen-based tuberculosis drug development - M. LyonsView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 201512_WiltshireView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015Concentration-response effects of combination therapy in a murine model of tuberculosis: optimizing the dosing regimen for short-course therapy - N. ZhangView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015The Systems Pharmacology Approach to Improve TB Treatment - Rada Savic, PharmD, PhDView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015Pharmacokinetics of rifampicin and moxifloxacin in the PanACEA-MAMS-TB-01 trial - R. AarnoutseView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015Contribution of different oxazolidinones to the efficacy of novel regimens containing bedaquiline and pretomanid in murine models of tuberculosis - R. TasneenView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015Pharmacodynamics of sulfamethoxazole in in vitro and in vivo models of tuberculosis - E. NuermbergerView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015Pharmacokinetics and pharmacodynamics of pyrazinoic acid in murine models of tuberculosis - J. LanoixView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015The Pharmacokinetics/Pharmacodynamics of Delamanid - Suresh Mallikaarjun, PhD, FCPView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 201504_DentiView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015Population pharmacokinetics and penetration of first and second line anti-TB drugs in pulmonary lesions from adults with active tuberculosis - S. GuptaView Slideset
ENEric NuermbergerMDSlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015Clofazimine: Current Status and Future Prospects - Eric Nuermberger, MDView Slideset
